Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Tanaka

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
Contemporary Clinical Trials Communications|July 11, 2022
Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipationAtsushi Yamamoto, Takaomi Kessoku, Kosuke Tanaka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2025
Erratum: Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Diagnostics (Basel, Switzerland)|August 10, 2024
A Handheld Ultrasound Device Can Predict Constipation with Rectal Fecal Retention in a Palliative Care SettingAtsushi Yamamoto, Takaomi Kessoku, Tomoki Ogata, et al.
Microbiome|January 28, 2025
The fungal microbiota modulate neonatal oxygen-induced lung injuryIsaac Martin, Mary Silverberg, Ahmed Abdelgawad, et al.
BMJ Open|May 31, 2022
Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipationKosuke Tanaka, Takaomi Kessoku, Atsushi Yamamoto, et al.
Clinical and Translational Gastroenterology|May 26, 2022
Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational StudyYuki Kasai, Takaomi Kessoku, Kosuke Tanaka, et al.
Nature|November 25, 2021
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancerHiroki Izumi, Shingo Matsumoto, Jie Liu, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Contemporary Clinical Trials Communications|July 11, 2022
Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipationAtsushi Yamamoto, Takaomi Kessoku, Kosuke Tanaka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2025
Erratum: Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Diagnostics (Basel, Switzerland)|August 10, 2024
A Handheld Ultrasound Device Can Predict Constipation with Rectal Fecal Retention in a Palliative Care SettingAtsushi Yamamoto, Takaomi Kessoku, Tomoki Ogata, et al.
Microbiome|January 28, 2025
The fungal microbiota modulate neonatal oxygen-induced lung injuryIsaac Martin, Mary Silverberg, Ahmed Abdelgawad, et al.
BMJ Open|May 31, 2022
Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipationKosuke Tanaka, Takaomi Kessoku, Atsushi Yamamoto, et al.
Clinical and Translational Gastroenterology|May 26, 2022
Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational StudyYuki Kasai, Takaomi Kessoku, Kosuke Tanaka, et al.
Nature|November 25, 2021
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancerHiroki Izumi, Shingo Matsumoto, Jie Liu, et al.
Pageof 20